RS1171616 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Propionylcarnitine levels | T | OR: 0.27 | 4E-110 | PubMed |
| Gout and other crystal arthrop (PheCode 274) | G | OR: 0.13 | 4E-53 | PubMed |
| Propionylcarnitine levels | G | OR: 0.24 | 1E-47 | PubMed |
| Acetylcarnitine levels | G | OR: 0.25 | 2E-45 | PubMed |
| Isobutyrylcarnitine levels | T | OR: 0.14 | 1E-30 | PubMed |
| Serum urate level in bendroflumethiazide treated hypertension | — | β: 0.061 | 2E-27 | PubMed |
| Total testosterone levels | — | β: 0.043 | 6E-27 | PubMed |
| Isovalerylcarnitine levels | T | OR: 0.12 | 9E-25 | PubMed |
| Butyrylcarnitine levels | G | OR: 0.18 | 5E-24 | PubMed |
| X-11381 levels | T | OR: 0.25 | 2E-22 | PubMed |
| Linoleoylcarnitine levels | T | OR: 0.12 | 3E-22 | PubMed |
| Urine X-17324 levels in chronic kidney disease | T | OR: 0.24 | 7E-22 | PubMed |
| Metabolite peak levels (QI7549) | T | OR: 0.32 | 2E-20 | PubMed |
| N,n-dimethylalanine (X-23585) levels | G | OR: 0.18 | 3E-19 | PubMed |
| Hexanoylcarnitine levels | G | OR: 0.16 | 1E-18 | PubMed |
| Gout | T | OR: 1.2 | 2E-17 | PubMed |
| N-methylproline levels | G | OR: 0.15 | 8E-17 | PubMed |
| Acylcarnitine (18:1) levels | T | OR: 0.21 | 3E-16 | PubMed |
| Degree of unsaturation | T | β: 0.02 | 1E-15 | PubMed |
| Acylcarnitine (14:0) levels | T | OR: 0.21 | 2E-15 | PubMed |